FVB/N mice are highly resistant to primary infection with Nippostrongylus brasiliensis.

Parasitology
Michelle L KnottL A Dent

Abstract

Nippostrongylus brasiliensis larvae are particularly susceptible to immunological attack during the pre-lung stage of primary and secondary infections in mice. Whilst most of the common laboratory strains of mice are permissive hosts for the parasite, in this study we report for the first time, the strong resistance of naive FVB/N mice to N. brasiliensis. Damage to larvae is evident within the first 24 h of infection and this may be critical to later larval development and reproductive success. Inflammatory responses in the skin, and larval escape from this tissue were comparable in susceptible CBA/Ca and resistant FVB/N mice, with most larvae exiting within 4 h of a primary infection. Lung larval burdens were also similar between strains, but larvae recovered from FVB/N mice were smaller and less motile. In FVB/N mice, larval colonization of the gut was impaired and worms produced very few eggs. However FVB/N mice did not show enhanced resistance to Heligmosomoides bakeri (also known as Heligmosomoides polygyrus), a nematode largely restricted to the gut. Damage done in the pre-lung or lung stages of infection with N. brasiliensis is likely to contribute to ongoing developmental and functional abnormalities, which are profound...Continue Reading

References

Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M TaketoC T Hansen
Nov 1, 1990·The Journal of Experimental Medicine·L A DentC J Sanderson
Feb 1, 1989·International Journal for Parasitology·C CrawfordD I Pritchard
Sep 1, 1985·Journal of Helminthology·D I Pritchard, J M Behnke
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E RothenbergP Leder
May 1, 1997·International Journal for Parasitology·Z Su, C Dobson
Jan 1, 1997·Memórias do Instituto Oswaldo Cruz·L A DentG Mayrhofer
Jan 1, 1997·Memórias do Instituto Oswaldo Cruz·K I MatthaeiI G Young
Feb 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J F UrbanF D Finkelman
Feb 26, 2000·Parasitology Today·E N Meeusen, A Balic
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D R HerbertD Abraham
Nov 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J F UrbanF D Finkelman
Dec 12, 2001·Parasite Immunology·F Nakamura-UchiyamaY Nawa
Mar 21, 2003·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Fuad A IraqiDerek R Wakelin
May 21, 2003·Journal of Helminthology·J M BehnkeD Wakelin
Jul 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aiping ZhaoTerez Shea-Donohue
Feb 20, 2004·Journal of Helminthology·A CywińskaA Schollenberger
Mar 20, 2004·Immunity·David VoehringerRichard M Locksley

❮ Previous
Next ❯

Citations

Mar 28, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sungwhan F OhCharles N Serhan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.